Literature DB >> 26753891

Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects.

Mohammad H Derakhshan1, Melina Arnold2, David H Brewster3, James J Going4, David R Mitchell1, David Forman2, Kenneth E L McColl1.   

Abstract

OBJECTIVES: The incidence of esophageal adenocarcinoma (EAC) is increasing while adenocarcinoma of the stomach is decreasing. We have investigated whether the incidences of these two cancers and their time trends might be inversely related pointing to a common environmental factor exerting opposite effects on these cancers.
METHODS: For cross-sectional analyses data were abstracted from "Cancer Incidence in Five Continents" (CI5) Volume X and GLOBOCAN 2012. Relevant ICD-10 codes were used to locate esophageal and gastric cancers anatomically, and ICD-O codes for the histological diagnosis of EAC. For longitudinal analyses, age standardized rates (ASRs) of EAC and total gastric cancer (TGC) were extracted from CI5C-Plus.
RESULTS: Estimated (2012) ASRs were available for 51 countries and these showed significant negative correlations between EAC and both TGC (males: correlation coefficient (CC)=-0.38, P=0.006, females: CC=-0.41, P=0.003) and non-cardia gastric cancer rates (males: CC=-0.41, P=0.003 and females: CC=-0.43, P=0.005). Annual incidence trends were analyzed for 38 populations through 1989-2007 and showed significant decreases for TGC in 89% and increases for EAC in 66% of these, with no population showing a fall in the latter. Significant negative correlation between the incidence trends of the two cancers was observed in 27 of the 38 populations over the 19-50 years of available paired data. Super-imposition of the longitudinal and cross-sectional data indicated that populations with a current high incidence of EAC and low incidence of gastric cancer had previously resembled countries with a high incidence of gastric cancer and low incidence of EAC.
CONCLUSIONS: The negative association between gastric cancer and EAC in both current incidences and time trends is consistent with a common environmental factor predisposing to one and protecting from the other.

Entities:  

Mesh:

Year:  2016        PMID: 26753891     DOI: 10.1038/ajg.2015.405

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  30 in total

1.  Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma.

Authors:  Martin J Blaser
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

2.  Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.

Authors:  Jennifer Drahos; Qian Xiao; Harvey A Risch; Neal D Freedman; Christian C Abnet; Lesley A Anderson; Leslie Bernstein; Linda Brown; Wong-Ho Chow; Marilie D Gammon; Farin Kamangar; Linda M Liao; Liam J Murray; Mary H Ward; Weimin Ye; Anna H Wu; Thomas L Vaughan; David C Whiteman; Michael B Cook
Journal:  Int J Cancer       Date:  2015-08-26       Impact factor: 7.396

3.  Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.

Authors:  M H Derakhshan; E El-Omar; K Oien; D Gillen; V Fyfe; J E Crabtree; K E L McColl
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

4.  Worldwide Burden of Gastric Cancer Attributable to Tobacco Smoking in 2012 and Predictions for 2020.

Authors:  Bárbara Peleteiro; Clara Castro; Samantha Morais; Ana Ferro; Nuno Lunet
Journal:  Dig Dis Sci       Date:  2015-03-19       Impact factor: 3.199

5.  Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.

Authors:  Svein Hansen; Stein Emil Vollset; Mohammad H Derakhshan; Valerie Fyfe; Kjetil K Melby; Steinar Aase; Egil Jellum; Kenneth E L McColl
Journal:  Gut       Date:  2007-02-22       Impact factor: 23.059

6.  Global incidence of oesophageal cancer by histological subtype in 2012.

Authors:  Melina Arnold; Isabelle Soerjomataram; Jacques Ferlay; David Forman
Journal:  Gut       Date:  2014-10-15       Impact factor: 23.059

7.  Comparative classification and grading of Helicobacter pylori gastritis in patients with gastric cancer and patients with functional dyspepsia.

Authors:  A Meining; A Kompisch; M Stolte
Journal:  Scand J Gastroenterol       Date:  2003-07       Impact factor: 2.423

8.  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease.

Authors:  F Cremonini; S Di Caro; S Delgado-Aros; A Sepulveda; G Gasbarrini; A Gasbarrini; M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2003-08-01       Impact factor: 8.171

9.  Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands.

Authors:  S Kroep; I Lansdorp-Vogelaar; J H Rubenstein; V E P P Lemmens; E B van Heijningen; N Aragonés; M van Ballegooijen; J M Inadomi
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

Review 10.  Environmental and lifestyle risk factors of gastric cancer.

Authors:  Yeong Yeh Lee; Mohammad H Derakhshan
Journal:  Arch Iran Med       Date:  2013-06       Impact factor: 1.354

View more
  14 in total

1.  The Relationship Between Gastric and Esophageal Cancers in Italy.

Authors:  Emanuele Crocetti; Silvia Mancini; Alessandra Ravaioli; Orietta Giuliani; Lauro Bucchi; Fabio Falcini
Journal:  Am J Gastroenterol       Date:  2016-08       Impact factor: 10.864

2.  Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.

Authors:  Melina Arnold; Mathieu Laversanne; Linda Morris Brown; Susan S Devesa; Freddie Bray
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

Review 3.  Past, present and future of Barrett's oesophagus.

Authors:  W K Tan; M di Pietro; R C Fitzgerald
Journal:  Eur J Surg Oncol       Date:  2017-02-16       Impact factor: 4.424

4.  Response to Crocetti et al.

Authors:  Mohammad H Derakhshan; Melina Arnold; David H Brewster; James J Going; David R Mitchell; David Forman; Kenneth E L McColl
Journal:  Am J Gastroenterol       Date:  2016-08       Impact factor: 10.864

5.  Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study.

Authors:  Marcis Leja; Jin Young Park; Raul Murillo; Inta Liepniece-Karele; Sergejs Isajevs; Ilze Kikuste; Dace Rudzite; Petra Krike; Sergei Parshutin; Inese Polaka; Arnis Kirsners; Daiga Santare; Valdis Folkmanis; Ilva Daugule; Martyn Plummer; Rolando Herrero
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

6.  Contrasting Prognostic Effects of Tumor-Infiltrating Lymphocyte Density in Cardia and Non-cardia Gastric Adenocarcinomas.

Authors:  Hyoung-Il Kim; Sang Yong Kim; Jae Eun Yu; Su-Jin Shin; Yun Ho Roh; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh; Chung-Gyu Park; Hyuk-Joon Lee
Journal:  J Gastric Cancer       Date:  2020-06-19       Impact factor: 3.720

7.  The efficacy of first-line regimens for Helicobacter pylori eradication in different continents: A systematic review and network meta-analysis protocol.

Authors:  Mohammad Zamani; Vahid Zamani; Mohammad H Derakhshan; Javad Shokri-Shirvani
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 8.  What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East?

Authors:  Kenneth E L McColl
Journal:  J Gastroenterol       Date:  2019-06-06       Impact factor: 7.527

9.  Dilated Thoracic Esophagus Presenting with Painful Progressive Persistent Dysphagia and Leukocytosis of Unknown Origin.

Authors:  Kyawzaw Lin; Jamil Shah; Emmanuel Ofori; Vahe Shahnazarian; Madhavi Reddy
Journal:  Cureus       Date:  2017-11-16

10.  Expressions of CD23, IL-17 and MMP-9 in Patients with Colorectal Cancer.

Authors:  Xueguang Guo; Gang Liu; Xiaoping Xie; Jing Li; Zehui Hou; Yanhong Gu; Lijiang Yu
Journal:  Iran J Public Health       Date:  2020-02       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.